Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Comments
Loading...

U.S. stock futures were mixed this morning, with the Dow futures falling more than 100 points on Monday.

Shares of Neurogene Inc. NGNE fell sharply in today's pre-market trading after the company announced it brought its high-dose gene therapy trial to a halt after a serious adverse event in a Rett syndrome patient.

Neurogene shares declined 37.7% to $21.50 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Rezolve AI Limited RZLV shares tumbled 16.1% to $2.29 in pre-market trading after dipping over 20% on Friday.
  • Kingsoft Cloud Holdings Limited KC shares dipped 12.3% to $4.43 in pre-market trading after gaining around 9% on Friday. Kingsoft Cloud will release its unaudited financial results for the third quarter before the opening bell on Nov. 19.
  • Luminar Technologies, Inc. LAZR tumbled 9.3% to $0.8890 in today's pre-market trading after declining around 5% on Friday.
  • Omeros Corporation OMER shares fell 7% to $6.28 in pre-market trading.
  • CompoSecure, Inc. CMPO shares declined 5.9% to $13.00 in pre-market trading.
  • Amgen Inc. AMGN shares fell 5.4% to $266.21 in pre-market trading following a 4% decline on Friday.
  • Intuitive Machines, Inc. LUNR shares fell 5% to $11.80 in pre-market trading after jumping 21% on Friday.
  • ProQR Therapeutics N.V. PRQR shares fell 4% to $3.67 in pre-market trading.
  • NVIDIA Corporation NVDA shares fell 2.4% to $138.51 in pre-market trading after declining more than 3% on Friday.

Now Read This:

Got Questions? Ask
How will Neurogene cope with trial halts?
Which biotech stocks could benefit from Neurogene's decline?
What are the implications for gene therapy investments?
Could AI stocks rebound after Rezolve AI's drop?
How will cloud service providers react to Kingsoft's earnings?
Which autonomous vehicle companies could gain from Luminar's struggles?
What opportunities arise for pharmaceutical firms post-Amgen's decline?
Could space tech stocks benefit from Intuitive Machines' volatility?
How does NVIDIA's performance affect AI chip manufacturers?
What trends in therapeutics should investors watch after ProQR's fall?
Market News and Data brought to you by Benzinga APIs

Posted In: